These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 7826624)

  • 21. Two independent activation domains in c-Ets-1 and c-Ets-2 located in non-conserved sequences of the ets gene family.
    Schneikert J; Lutz Y; Wasylyk B
    Oncogene; 1992 Feb; 7(2):249-56. PubMed ID: 1549346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exon 4-encoded acidic domain in the epithelium-restricted Ets factor, ESX, confers potent transactivating capacity and binds to TATA-binding protein (TBP).
    Chang CH; Scott GK; Baldwin MA; Benz CC
    Oncogene; 1999 Jun; 18(25):3682-95. PubMed ID: 10391676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of Ets function by protein - protein interactions.
    Li R; Pei H; Watson DK
    Oncogene; 2000 Dec; 19(55):6514-23. PubMed ID: 11175367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of the human leukemia inhibitory factor gene by ETS transcription factors.
    Bamberger AM; Jenatschke S; Schulte HM; Ellebrecht I; Beil FU; Bamberger CM
    Neuroimmunomodulation; 2004; 11(1):10-9. PubMed ID: 14557674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of ETS-1 and ERGB/FLI-1 proteins with DNA is modulated by spacing between multiple binding sites as well as phosphorylation.
    Hodge DR; Robinson L; Watson D; Lautenberger J; Zhang XK; Venanzoni M; Seth A
    Oncogene; 1996 Jan; 12(1):11-8. PubMed ID: 8552380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The oncoprotein v-Ets is less selective in DNA binding than c-Ets-1 due to the C-terminal sequence change.
    Hahn SL; Wasylyk B
    Oncogene; 1994 Sep; 9(9):2499-512. PubMed ID: 8058313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localization and modulation of the DNA-binding activity of the human c-ets-1 protooncogene.
    Reddy ES; Rao VN
    Cancer Res; 1990 Aug; 50(16):5013-6. PubMed ID: 2165853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular and viral trans-acting factors modulate N-myc2 promoter activity in woodchuck liver tumors.
    Flajolet M; Gegonne A; Ghysdael J; Tiollais P; Buendia MA; Fourel G
    Oncogene; 1997 Aug; 15(9):1103-10. PubMed ID: 9285565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncogenic conversion alters the transcriptional properties of ets.
    Wasylyk C; Wasylyk B
    Cell Growth Differ; 1992 Sep; 3(9):617-25. PubMed ID: 1329927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-2 and long-term T cell activation induce physical and functional interaction between STAT5 and ETS transcription factors in human T cells.
    Rameil P; Lécine P; Ghysdael J; Gouilleux F; Kahn-Perlès B; Imbert J
    Oncogene; 2000 Apr; 19(17):2086-97. PubMed ID: 10815800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ets up-regulates MET transcription.
    Gambarotta G; Boccaccio C; Giordano S; Andŏ M; Stella MC; Comoglio PM
    Oncogene; 1996 Nov; 13(9):1911-7. PubMed ID: 8934537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequence specific binding of Ets-1 to the mouse cytokeratin EndoA gene enhancer.
    Hamazato F; Fujimura Y; Tamai Y; Takemoto Y; Matsushiro A; Nozaki M
    Biochem Biophys Res Commun; 1993 Apr; 192(2):430-8. PubMed ID: 7683460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. c-ets-1 DNA binding to the PEA3 motif is differentially inhibited by all the mutations found in v-ets.
    Leprince D; Crepieux P; Stehelin D
    Oncogene; 1992 Jan; 7(1):9-17. PubMed ID: 1741168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The c-ets-1 proto-oncogene has oncogenic activity and is positively autoregulated.
    Seth A; Papas TS
    Oncogene; 1990 Dec; 5(12):1761-7. PubMed ID: 2284095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ets-1 and ets-2 proto-oncogene expression in human leukemia cells and cell lines.
    Dreyfus F; Picard F; Gisselbrecht S; Varet B; Tambourin PE; Fichelson S
    Nouv Rev Fr Hematol (1978); 1989; 31(3):217-21. PubMed ID: 2694094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure, expression and alternative splicing of the human c-ets-1 proto-oncogene.
    Reddy ES; Rao VN
    Oncogene Res; 1988; 3(3):239-46. PubMed ID: 3060801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Oncogenes as probes for cellular signal processes: the family of ETS genes".
    Papas TS
    AIDS Res Hum Retroviruses; 1992 May; 8(5):824-33. PubMed ID: 1515233
    [No Abstract]   [Full Text] [Related]  

  • 38. An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene.
    Hagman J; Grosschedl R
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8889-93. PubMed ID: 1409581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phylogeny of the p68c-ets-1 amino-terminal transactivating domain reveals some highly conserved structural features.
    Albagli O; Flourens A; Crepieux P; Begue A; Stehelin D; Leprince D
    Oncogene; 1992 Jul; 7(7):1435-9. PubMed ID: 1620554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A residue of the ETS domain mutated in the v-ets oncogene is essential for the DNA-binding and transactivating properties of the ETS-1 and ETS-2 proteins.
    Soudant N; Albagli O; Dhordain P; Flourens A; Stéhelin D; Leprince D
    Nucleic Acids Res; 1994 Sep; 22(19):3871-9. PubMed ID: 7937106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.